Nomura Holdings’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-8,650
| Closed | -$351K | – | 1772 |
|
|
2025
Q4 | $351K | Sell |
8,650
-13,451
| -61% | -$585K | ﹤0.01% | 1629 |
|
|
2025
Q3 | $1.04M | Buy |
+22,101
| New | +$1.15M | ﹤0.01% | 1380 |
|
|
2025
Q2 | – | Sell |
-77,077
| Closed | -$4.65M | – | 1534 |
|
|
2025
Q1 | $4.65M | Sell |
77,077
-25,121
| -25% | -$1.62M | 0.01% | 737 |
|
|
2024
Q4 | $6.99M | Sell |
102,198
-35,048
| -26% | -$2.44M | 0.01% | 642 |
|
|
2024
Q3 | $9.87M | Sell |
137,246
-8,571
| -6% | -$605K | 0.02% | 438 |
|
|
2024
Q2 | $10.1M | Sell |
145,817
-1,174
| -0.8% | -$85.6K | 0.02% | 444 |
|
|
2024
Q1 | $11.8M | Sell |
146,991
-31,158
| -17% | -$2.78M | 0.03% | 391 |
|
|
2023
Q4 | $19.5M | Buy |
178,149
+8,153
| +5% | +$843K | 0.05% | 282 |
|
|
2023
Q3 | $17.1M | Sell |
169,996
-180,249
| -51% | -$20.7M | 0.05% | 250 |
|
|
2023
Q2 | $47.6M | Buy |
350,245
+10,454
| +3% | +$1.28M | 0.13% | 127 |
|
|
2023
Q1 | $35.3M | Buy |
339,791
+181,741
| +115% | +$17.6M | 0.11% | 140 |
|
|
2022
Q4 | $14M | Sell |
158,050
-247,958
| -61% | -$20.6M | 0.06% | 246 |
|
|
2022
Q3 | $32.6M | Buy |
406,008
+171,813
| +73% | +$16.2M | 0.13% | 124 |
|
|
2022
Q2 | $22.7M | Buy |
234,195
+205,045
| +703% | +$24.6M | 0.08% | 151 |
|
|
2022
Q1 | $4.37M | Sell |
29,150
-3,914
| -12% | -$547K | 0.01% | 661 |
|
|
2021
Q4 | $4.7M | Buy |
33,064
+25,143
| +317% | +$3.56M | 0.01% | 717 |
|
|
2021
Q3 | $1.06M | Sell |
7,921
-13,900
| -64% | -$1.82M | ﹤0.01% | 1105 |
|
|
2021
Q2 | $3.01M | Sell |
21,821
-528
| -2% | -$72.3K | 0.01% | 726 |
|
|
2021
Q1 | $2.93M | Buy |
+22,349
| New | +$2.69M | 0.01% | 728 |
|
|
2020
Q4 | – | Sell |
-20,000
| Closed | -$1.57M | – | 1534 |
|
|
2020
Q3 | $1.57M | Sell |
20,000
-29,909
| -60% | -$2.44M | ﹤0.01% | 709 |
|
|
2020
Q2 | $3.56M | Sell |
49,909
-26,753
| -35% | -$1.86M | 0.01% | 451 |
|
|
2020
Q1 | $4.38M | Buy |
76,662
+12,000
| +19% | +$1.11M | 0.02% | 342 |
|
|
2019
Q4 | $7.22M | Buy |
64,662
+31,528
| +95% | +$3.36M | 0.03% | 377 |
|
|
2019
Q3 | $3.1M | Sell |
33,134
-44,366
| -57% | -$4.17M | 0.01% | 562 |
|
|
2019
Q2 | $6.63M | Sell |
77,500
-17,940
| -19% | -$1.47M | 0.03% | 404 |
|
|
2019
Q1 | $7.87M | Buy |
+95,440
| New | +$6.93M | 0.03% | 351 |
|
|
2014
Q4 | – | Sell |
-7,920
| Closed | -$298K | – | 2347 |
|
|
2014
Q3 | $298K | Buy |
+7,920
| New | +$314K | ﹤0.01% | 2175 |
|
|
2014
Q1 | – | Sell |
-10,569
| Closed | -$449K | – | 2742 |
|
|
2013
Q4 | $449K | Buy |
+10,569
| New | +$402K | ﹤0.01% | 1336 |
|
Other funds holding CNMD
CB
Nomura Holdings's CNMD Position: Q1 2026 in Review
Nomura Holdings sold out of CONMED (CNMD) in Q1 2026, closing a stake of 8,650 shares — an estimated $351K sold.
Nomura Holdings first reported a position in CNMD in Q4 2013 and held it in 28 quarters. The position peaked at $47.6M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Nomura Holdings reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
- Nomura Holdings sold 8,650 CONMED shares in Q1 2026, an estimated $351K.
- Nomura Holdings first reported a position in CONMED in Q4 2013 and held it in 28 quarters.
- Nomura Holdings's CONMED position peaked at $47.6M in Q2 2023.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.